BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

98 related articles for article (PubMed ID: 6797209)

  • 1. Protein turnover in acute and chronic liver disease.
    O'Keefe SJ; Abraham RR; Davis M; Williams R
    Acta Chir Scand Suppl; 1981; 507():91-101. PubMed ID: 6797209
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Contribution of elevated protein turnover and anorexia to cachexia in patients with hepatocellular carcinoma.
    O'Keefe SJ; Ogden J; Ramjee G; Rund J
    Cancer Res; 1990 Feb; 50(4):1226-30. PubMed ID: 2153453
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Role of meal carbohydrate content for the imbalance of plasma amino acids in patients with liver cirrhosis.
    Schulte-Frohlinde E; Wagenpfeil S; Willis J; Lersch C; Eckel F; Schmid R; Schusdziarra V
    J Gastroenterol Hepatol; 2007 Aug; 22(8):1241-8. PubMed ID: 17688664
    [TBL] [Abstract][Full Text] [Related]  

  • 4. [Therapy of aminoacid and protein metabolism disturbances in liver disease (author's transl)].
    Gerok W
    Leber Magen Darm; 1981 Apr; 11(2):63-72. PubMed ID: 6785546
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Nutrition in the management of hepatic encephalopathy.
    Srivastava N; Singh N; Joshi YK
    Trop Gastroenterol; 2003; 24(2):59-62. PubMed ID: 14603821
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Effects of branched-chain amino acid infusion on protein metabolism in rats with acute hepatic failure.
    Miwa Y; Kato M; Moriwaki H; Okuno M; Sugihara J; Ohnishi H; Yoshida T; Muto Y; Nakayama M; Morioka Y
    Hepatology; 1995 Jul; 22(1):291-6. PubMed ID: 7601423
    [TBL] [Abstract][Full Text] [Related]  

  • 7. [Blood amino acids in chronic HBsAg positive liver disease].
    De Marco F; Palmieri G; Capuano G; Gentile R; Nardone G; Parrilli G; Prantera T; Budillon G
    Boll Soc Ital Biol Sper; 1983 Oct; 59(10):1576-81. PubMed ID: 6661322
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Regulation of urea synthesis by diet protein and carbohydrate in normal man and in patients with cirrhosis. Relationship to glucagon and insulin.
    Hamberg O
    Dan Med Bull; 1997 Jun; 44(3):225-41. PubMed ID: 9233544
    [TBL] [Abstract][Full Text] [Related]  

  • 9. [Liver cirrhosis and encephalopathy: clinical and metabolic consequences and nutritional support].
    Mesejo A; Juan M; Serrano A
    Nutr Hosp; 2008 May; 23 Suppl 2():8-18. PubMed ID: 18714406
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Nutritional treatment with branched-chain amino acids in advanced liver cirrhosis.
    Marchesini G; Bianchi G; Rossi B; Brizi M; Melchionda N
    J Gastroenterol; 2000; 35 Suppl 12():7-12. PubMed ID: 10779207
    [TBL] [Abstract][Full Text] [Related]  

  • 11. [Parenteral and enteral nutritional support for patients with liver cirrhosis].
    Masuzawa M; Okuyama T; Kato M
    Nihon Rinsho; 1994 Jan; 52(1):203-8. PubMed ID: 8114294
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Nutritional modulation of protein metabolism after gastrointestinal surgery.
    López Hellín J; Baena-Fustegueras JA; Sabín-Urkía P; Schwartz-Riera S; García-Arumí E
    Eur J Clin Nutr; 2008 Feb; 62(2):254-62. PubMed ID: 17375114
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Branched-chain amino acid-enriched supplementation improves insulin resistance in patients with chronic liver disease.
    Kawaguchi T; Nagao Y; Matsuoka H; Ide T; Sata M
    Int J Mol Med; 2008 Jul; 22(1):105-12. PubMed ID: 18575782
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Nutritional support of patients with severe hepatic failure.
    Barber JR; Teasley KM
    Clin Pharm; 1984; 3(3):245-53. PubMed ID: 6428797
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Standard or branched-chain amino acid infusions as short-term nutritional support in liver cirrhosis?
    Rocchi E; Cassanelli M; Gibertini P; Pietrangelo A; Casalgrandi G; Ventura E
    JPEN J Parenter Enteral Nutr; 1985; 9(4):447-51. PubMed ID: 3928919
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Increased plasma tyrosine concentrations in patients with cirrhosis and fulminant hepatic failure associated with increased plasma tyrosine flux and reduced hepatic oxidation capacity.
    O'Keefe SJ; Abraham R; El-Zayadi A; Marshall W; Davis M; Williams R
    Gastroenterology; 1981 Dec; 81(6):1017-24. PubMed ID: 7286580
    [No Abstract]   [Full Text] [Related]  

  • 17. Estimation of protein intake using urinary urea nitrogen in patients with liver cirrhosis.
    Kida Y
    Scand J Gastroenterol; 2009; 44(5):615-8. PubMed ID: 19137458
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Severe catabolic state after prolonged fasting in cirrhotic patients: effect of oral branched-chain amino-acid-enriched nutrient mixture.
    Nakaya Y; Harada N; Kakui S; Okada K; Takahashi A; Inoi J; Ito S
    J Gastroenterol; 2002; 37(7):531-6. PubMed ID: 12162411
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Dietary protein supplementation from vegetable sources in the management of chronic portal systemic encephalopathy.
    Keshavarzian A; Meek J; Sutton C; Emery VM; Hughes EA; Hodgson HJ
    Am J Gastroenterol; 1984 Dec; 79(12):945-9. PubMed ID: 6391154
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Metabolic effects of liver transplantation in cirrhotic patients.
    Luzi L; Perseghin G; Regalia E; Sereni LP; Battezzati A; Baratti D; Bianchi E; Terruzzi I; Hilden H; Groop LC; Pulvirenti A; Taskinen MR; Gennari L; Mazzaferro V
    J Clin Invest; 1997 Feb; 99(4):692-700. PubMed ID: 9045872
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 5.